PUBLISHER: The Business Research Company | PRODUCT CODE: 1426390
PUBLISHER: The Business Research Company | PRODUCT CODE: 1426390
Invasive Fungal Infections Global Market Report 2024
Invasive fungal infections are severe diseases caused by pathogenic fungi that penetrate and spread within the body, extending beyond the point of initial infection. These infections involve the penetration of fungal organisms into deeper layers of tissue, including the bloodstream, organs, or other body structures. The treatment of invasive fungal infections typically includes the use of antifungal medications and, in certain instances, surgical procedures to excise infected tissue.
The main types of invasive fungal infections encompass candidemia and invasive candidiasis, intraabdominal candidiasis, cryptococcal meningitis, esophageal candidiasis, histoplasmosis acute pulmonary, and others. Candidemia and invasive candidiasis, for instance, are infections caused by Candida fungus that can affect various parts of the body, including the blood, heart, brain, eyes, bones, or other organs. Treatment involves the use of different drug types, such as polyenes, triazoles, echinocandins, flucytosine, and others, and is administered by various end-users, including hospitals, homecare, specialty clinics, and others.
The invasive fungal infections market research report is one of a series of new reports from The Business Research Company that provides invasive fungal infections market statistics, including invasive fungal infections industry global market size, regional shares, competitors with a invasive fungal infections market share, detailed invasive fungal infections market segments, market trends and opportunities, and any further data you may need to thrive in the invasive fungal infections industry. This invasive fungal infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The invasive fungal infections market size has grown strongly in recent years. It will grow from $7.21 billion in 2023 to $7.58 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to the global spread of infections, hematopoietic stem cell transplants, an aging population, hospital-acquired infections, and environmental factors.
The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.08 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to global health preparedness, public health education, the development of novel antifungal agents, the impact of climate change, and multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, and collaborations for drug development.
The projected increase in the population afflicted by Human Immunodeficiency Virus (HIV) is anticipated to propel the expansion of the invasive fungal infection market in the coming years. HIV is a virus that compromises the immune system's ability to combat diseases and infections. As the number of individuals with compromised immune systems, including those affected by HIV or AIDS, rises, susceptibility to invasive fungal infections escalates. This surge creates opportunities for manufacturers to develop and supply specialized and more effective antifungal drugs. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2023, the global population living with HIV increased to 39 million in 2022, marking a 3.17% rise from 37.7 million in 2020. Additionally, approximately 1.3 million new HIV infections were reported in 2022. Hence, the anticipated rise in the population affected by HIV is expected to drive the growth of the invasive fungal infection market.
The mounting number of cancer patients is forecasted to fuel the expansion of the invasive fungal infections market in the future. Invasive fungal infections (IFIs) pose severe and potentially life-threatening complications for cancer patients, particularly those with weakened immune systems. The growing population of cancer survivors is a significant factor contributing to the increased risk of IFIs among these individuals. As reported by the National Cancer Institute in November 2022, it is projected that by 2040, there will be approximately 26.0 million cancer survivors. Furthermore, the number of individuals who have survived five or more years after a cancer diagnosis is expected to surge by nearly 30%, reaching 16.3 million over the subsequent decade. Consequently, the escalating number of cancer patients and survivors stands as a driving force behind the growth of the invasive fungal infections market.
The emergence of drug-resistant fungal strains represents a notable challenge that may impede the growth of the invasive fungal infection market during the forecast period. The appearance of these resistant strains poses a substantial hurdle in the treatment of invasive fungal infections. With evolving defenses that enable survival against modern medicines, these strains compromise the efficacy of antifungal drugs, complicating the treatment of patients affected by such infections. For instance, as reported by CIDRAP (Center for Infectious Disease Research and Policy) in March 2023, there was a concerning 95% increase in Candida auris followed by a 59% rise in 2020. This spike in drug-resistant fungal strains highlights a significant obstacle and contributes to hindering the growth trajectory of the invasive fungal infection market.
Prominent companies operating within the invasive fungal infection market are dedicated to developing advanced antifungal drugs, such as Posaconazole, to meet the escalating demand for more effective and innovative treatments for fungal infections, aiming to attain a competitive advantage in the market. Antifungal medications such as Posaconazole are specifically designed to combat fungal infections by either inhibiting their growth or eradicating the fungi responsible for the infection. For instance, in June 2021, Cadila Pharmaceuticals Ltd., a renowned pharmaceutical company based in India, introduced Posaconazole, a novel triazole antifungal drug. This drug demonstrates efficacy against various invasive fungal diseases and is recommended as a secondary treatment for mucormycosis (black fungus). Approved for preventing aspergillus and candida infections in immunocompromised patients, as well as for treating oropharyngeal candidiasis (OPC), Posaconazole represents an innovative addition to the arsenal of treatments available for these fungal infections.
In April 2021, Pfizer Inc., a prominent US-based pharmaceutical company, completed the acquisition of Amplyx Pharmaceuticals, Inc. for an undisclosed sum. This strategic acquisition marks Pfizer's expansion in the realm of infectious diseases and anti-infectives by incorporating a promising Phase 2 antifungal candidate, Fosmanogepix (APX001), specifically developed for the treatment of invasive fungal infections. Amplyx Pharmaceuticals, Inc., a US-based pharmaceutical company renowned for its focus on pioneering therapies targeting life-threatening diseases, notably invasive fungal infections, provided Pfizer with this innovative antifungal candidate as part of the acquisition.
Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK plc, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMerieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd, F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB
North America was the largest region in the invasive fungal infections market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the invasive fungal infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The invasive fungal infections market consists of revenues earned by entities by providing services such as diagnostic testing, clinical research and development, educational programs, and awareness campaign services. The market value includes the value of related goods sold by the service provider or included within the service offering. The invasive fungal infections market also includes sales of azoles, allylamines, and morpholines, which are used in treating invasive fungal infections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Invasive Fungal Infections Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on invasive fungal infections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for invasive fungal infections? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The invasive fungal infections market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Scope
Markets Covered:
- 1) By Disease Type: Candidaemi And Invasive Candidiasis; Intra Abdominal Candidiasis; Cryptococcal Meningitis; Esophageal Candidiasis; Histoplasmosis Acute Pulmonary; Other Disease Type
- 2) By Drug Type: Polyenes; Triazoles; Echinocandins; Flucytosine; Other Drug Type
- 3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
- Companies Mentioned: Pfizer Inc.; Merck And Co. Inc.; Bayer AG; Abbott Laboratories; GSK plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Invasive Fungal Infections Market Characteristics
3. Invasive Fungal Infections Market Trends And Strategies
4. Invasive Fungal Infections Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Invasive Fungal Infections Market Size and Growth
- 5.1. Global Invasive Fungal Infections Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Invasive Fungal Infections Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Invasive Fungal Infections Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Invasive Fungal Infections Market Segmentation
- 6.1. Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Candidaemi And Invasive Candiasis
- Intra Abdominal Candiasis
- Cryptococcal Meningitis
- Esophageal Candidiasis
- Histoplasmosis Acute Pulmonary
- Other Disease Types
- 6.2. Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Polyenes
- Triazoles
- Echinocandins
- Flucytosine
- Other Drug Types
- 6.3. Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End-Users
7. Invasive Fungal Infections Market Regional And Country Analysis
- 7.1. Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Invasive Fungal Infections Market
- 8.1. Asia-Pacific Invasive Fungal Infections Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Invasive Fungal Infections Market
- 9.1. China Invasive Fungal Infections Market Overview
- 9.2. China Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Invasive Fungal Infections Market
- 10.1. India Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Invasive Fungal Infections Market
- 11.1. Japan Invasive Fungal Infections Market Overview
- 11.2. Japan Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Invasive Fungal Infections Market
- 12.1. Australia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Invasive Fungal Infections Market
- 13.1. Indonesia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Invasive Fungal Infections Market
- 14.1. South Korea Invasive Fungal Infections Market Overview
- 14.2. South Korea Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Invasive Fungal Infections Market
- 15.1. Western Europe Invasive Fungal Infections Market Overview
- 15.2. Western Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Invasive Fungal Infections Market
- 16.1. UK Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Invasive Fungal Infections Market
- 17.1. Germany Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Invasive Fungal Infections Market
- 18.5. France Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.6. France Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.7. France Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Invasive Fungal Infections Market
- 19.9. Italy Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.10. Italy Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.11. Italy Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Invasive Fungal Infections Market
- 20.13. Spain Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.14. Spain Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.15. Spain Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Invasive Fungal Infections Market
- 21.1. Eastern Europe Invasive Fungal Infections Market Overview
- 21.2. Eastern Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Invasive Fungal Infections Market
- 22.1. Russia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Invasive Fungal Infections Market
- 23.1. North America Invasive Fungal Infections Market Overview
- 23.2. North America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Invasive Fungal Infections Market
- 24.1. USA Invasive Fungal Infections Market Overview
- 24.2. USA Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Invasive Fungal Infections Market
- 25.1. Canada Invasive Fungal Infections Market Overview
- 25.2. Canada Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Invasive Fungal Infections Market
- 26.1. South America Invasive Fungal Infections Market Overview
- 26.2. South America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Invasive Fungal Infections Market
- 27.1. Brazil Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Invasive Fungal Infections Market
- 28.1. Middle East Invasive Fungal Infections Market Overview
- 28.2. Middle East Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Invasive Fungal Infections Market
- 29.1. Africa Invasive Fungal Infections Market Overview
- 29.2. Africa Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Invasive Fungal Infections Market Competitive Landscape And Company Profiles
- 30.1. Invasive Fungal Infections Market Competitive Landscape
- 30.2. Invasive Fungal Infections Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Merck And Co. Inc.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Abbott Laboratories
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. GSK plc
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Pfizer Inc.
31. Invasive Fungal Infections Market Other Major And Innovative Companies
- 31.1. Gilead Sciences Inc.
- 31.2. Siemens Healthineers
- 31.3. Mylan N.V.
- 31.4. Astellas Pharma Inc.
- 31.5. Quest Diagnostics Incorporated
- 31.6. Sun Pharmaceutical Industries Ltd.
- 31.7. BioMerieux SA
- 31.8. BioMarin Pharmaceutical Inc.
- 31.9. Xellia Pharmaceuticals
- 31.10. Basilea Pharmaceutica
- 31.11. Cidara Therapeutic Inc.
- 31.12. Pulmocide Ltd.
- 31.13. NovaBiotics Ltd
- 31.14. F2G Ltd.
- 31.15. Giner Inc.
32. Global Invasive Fungal Infections Market Competitive Benchmarking
33. Global Invasive Fungal Infections Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Invasive Fungal Infections Market
35. Invasive Fungal Infections Market Future Outlook and Potential Analysis
- 35.1 Invasive Fungal Infections Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Invasive Fungal Infections Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Invasive Fungal Infections Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
